GT Biopharma
GTBP
GTBP
38 hedge funds and large institutions have $374K invested in GT Biopharma in 2025 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
63% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 8
Holders
38
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$38.9K | |
| 2 | +$35.5K | |
| 3 | +$29.2K | |
| 4 |
Jane Street
New York
|
+$18.5K |
| 5 |
IWC
Integrated Wealth Concepts
Waltham,
Massachusetts
|
+$14.2K |
Top Sellers
| 1 | -$83.5K | |
| 2 | -$58K | |
| 3 | -$6.25K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$3.34K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$3.22K |
